Using spectrum techniques and density functional theory (DFT) reckonings, structural, vibrational and electrical characteristics of Bis(8‑hydroxy quinoline) salicylate salicylic acid (8HQSA) were determined. Characterizing the chemical under inquiry involved employing FT-IR, FT-Raman, UV–vis spectral studies and single crystal X-ray diffraction (SCXRD). For the characterization, the B3LYP approach inside the structure of DFT was employed, with a 6–311++G(d,p) basis set. The structural study shows that the stability of 8HQSA crystalline structure arising from N–H⋯O, C–O⋯H and O–H⋯O hydrogen bonding interactions. The 1H and 13C NMR chemical shifts were calculated using Gauge Independent Atomic Orbital (GIAO) technical. Vibrational frequencies and molecular geometry were computed and likened with experimental data. Here, non-covalent interactions were deeply analyzed in terms of topological parameters (AIM), electron localization function (ELF), localized orbital locator (LOL), Hirshfeld surface and reduced density gradient (RDG) method. Weak interactions such as H-bonds, van der Waals and steric effect in 8HQSA were visualized and quantified by the independent gradient density (IGM) based on the trimolecular density. The hyper-conjugative and the delocalization of charge in 8HQSA have been elucidated by natural bonding orbital (NBO) while its chemical reactivity was studied and discussed by using molecular electrostatic potential surface (MEP), frontier molecular orbital (FMOs), density of state (DOS) and partial density of state (PDOS). The positions of the molecule's nucleophilic and electrophilic groups were ascertained using Fukui analysis. To describe the size, structure, and reactive sites of the molecules, the molecular electrostatic potential and total electron density are calculated. With a band gap (2.58 eV), FMO study indicates that the material is both bioactive and stable. The ADMET factor and drug similarity are used to predict 8HQSA's pharmokinetic characteristics. Based on the findings, it can be concluded that the 8HQSA particle is optimally crystallised and recommended as a preventative measure against bacterial and fungal infections. The stability of the title compound has been investigated via molecular dynamics simulations. In-vitro antimicrobial activity results clearly reveal that in all the four strains, activity increases with increase in compound concentration and the inhibition of the strains also increases. From both molecular docking and In-vitro Antimicrobial Activity the title compound can be certified that it inhibits antimicrobial activity.